Halbert Hargrove Global Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-29
Closed -$2.76K 592
2025
Q3
$2.76K Buy
+29
New +$2.67K ﹤0.01% 508
2025
Q2
Sell
-2
Closed -$180 511
2025
Q1
$180 Buy
+2
New +$179 ﹤0.01% 599
2020
Q1
Sell
-1,784
Closed -$202K 91
2019
Q4
$202K Buy
+1,784
New +$196K 0.05% 87
2017
Q3
Sell
-2,358
Closed -$209K 71
2017
Q2
$209K Buy
+2,358
New +$199K 0.06% 66
2016
Q4
Sell
-2,689
Closed -$232K 76
2016
Q3
$232K Sell
2,689
-271
-9% -$23.6K 0.07% 59
2016
Q2
$257K Sell
2,960
-404
-12% -$32.7K 0.07% 58
2016
Q1
$252K Sell
3,364
-605
-15% -$45.6K 0.09% 65
2015
Q4
$305K Buy
3,969
+217
+6% +$16.3K 0.13% 63
2015
Q3
$251K Sell
3,752
-7,436
-66% -$548K 0.12% 73
2015
Q2
$829K Sell
11,188
-690
-6% -$52.7K 0.2% 38
2015
Q1
$926K Buy
11,878
+5,738
+93% +$435K 0.3% 34
2014
Q4
$443K Sell
6,140
-91
-1% -$6.32K 0.22% 49
2014
Q3
$386K Buy
6,231
+441
+8% +$28K 0.11% 78
2014
Q2
$369K Buy
5,790
+31
+0.5% +$1.88K 0.11% 69
2014
Q1
$354K Sell
5,759
-347
-6% -$20.2K 0.11% 67
2013
Q4
$350K Buy
+6,106
New +$346K 0.11% 69

Other funds holding MDT

Halbert Hargrove Global Advisors's MDT Position: Q4 2025 in Review

Halbert Hargrove Global Advisors sold out of Medtronic (MDT) in Q4 2025, closing a stake of 29 shares — an estimated $2.76K sold.

Halbert Hargrove Global Advisors first reported a position in MDT in Q4 2013 and held it in 16 quarters. The position peaked at $926K in Q1 2015. 2,303 funds tracked by Wall St. Rank hold MDT as of Q4 2025.

  • Halbert Hargrove Global Advisors reported no remaining Medtronic position as of Q4 2025 after selling out during the quarter.
  • Halbert Hargrove Global Advisors sold 29 Medtronic shares in Q4 2025, an estimated $2.76K.
  • Halbert Hargrove Global Advisors first reported a position in Medtronic in Q4 2013 and held it in 16 quarters.
  • Halbert Hargrove Global Advisors's Medtronic position peaked at $926K in Q1 2015.
  • 2,303 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.

Based on Halbert Hargrove Global Advisors's 13F filing for Q4 2025, filed 23 Jan 2026.